Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Considering the challenges posed by technology that tracks whether you took your meds

Considering the challenges posed by technology that tracks whether you took your meds

One fairly recent entrant into the world of digital health is a pill that detects when it is ingested, then sends a signal to an app and to people the patient designates, such as clinicians or family members.

The technology joins a collection of other digital devices that are being developed or are already in use to monitor health, such as a meter that measures glucose levels for diabetes patients and a mobile device that tracks the number of steps a heart patient takes every day.

In a recent paper published in the American Journal of Bioethics, a Stanford psychiatrist and three other bioethicists note the potential benefits of the emerging technologies — they can gather more accurate information about how patients are taking their medication and potentially improve patient outcomes and lower the number of hospitalizations. But the researchers also call for more study of many potential ethical issues they introduce.

“Digital medicine — combining technological advances in information technology, artificial intelligence, and big data with those of pharmaceutical, biotechnology, and medical device companies — represents a bold new frontier in medical care,” wrote the authors, who include Laura B. Dunn, MD, Stanford professor of psychiatry and behavioral sciences. “Accompanying these technological advances are emerging ethical issues, engendered by the rapid pace of technology and the challenges of managing vast amounts of patients’ medical, behavioral and personal information.”

Included in their examples of emerging self-acting technology is a new drug, called Abilify MyCite, that gained FDA approval last year and is undergoing a limited rollout in the United States. The digital pill, developed by the Otsuka Pharmaceutical company, combines sensor technology with Abilify, which is used to treat a range of serious mental illnesses. In practice, a psychiatrist who prescribes it to a patient with schizophrenia might be better positioned to help that patient if they are certain he or she is taking the medicine as prescribed, the authors said.

But the authors also laid out multiple ethical considerations they said should be examined amid the quickly growing development of many kinds of self-acting devices and uses in digital medication.

Among them are whether patients fully understand how their health information may be collected, used, stored and shared. Other considerations are whether access to digital medicine will be equitable, as well as the impact on clinicians of prescribing them to patients. For example, what is their obligation to check the data? Would they be liable for bad outcomes? And would they be subject to external monitoring, for example, from insurers or drug companies?

Of particular concern, Dunn said, is the potential negative effect on the doctor-patient relationship, especially with regard to mutual trust. Dunn, who is one of four authors on the article, said that psychiatrists would likely agree that the goal of prescribing something like Abilify MyCite would be to enhance relationships with a patients, not to replace those relationships.

“It could lead to a better relationship because patients are sharing more data” that can be helpful, in the same way data from fitness tracking devices might be, Dunn said. But she echoes the article’s theme that a cautious approach is essential, and more study is needed on how physicians and patients view the new technology.

“I would view it as another tool that could be useful in the relationship, but I also I would have to be careful, as a psychiatrist, how I use it — as I would be with any tool,” said Dunn, who has not prescribed digital medicine in her own practice.

Besides Dunn, the article’s authors include bioethics experts Craig Klugman, PhD; Jack Schwartz, JD; and Glenn Cohen, JD. The four have served as consultants for Otsuka Pharmaceuticals, advising on ethical issues related to the use of digital medicine, but they noted that the company did not fund the research for the article, nor did the company play any role in the conceptualization, drafting, revising or reviewing of the article.

Image by RonnyK

Tagged with:

About author

Related Articles